MANGOCEUTICALS, INC. — Form 8-K
Filed October 9, 2026 · analyzed by the 8-K Agent
8-K
— Neutral
significance 28/100
What the filing says
Mangoceuticals, Inc. (NASDAQ: MGRX) closed a registered direct offering on October 9, 2026, raising approximately $492,750 by issuing 657,000 shares of common stock and 657,000 warrants at $0.75 per unit (74% premium to $0.43 recent close). Each warrant is exercisable at $1.00/share for five years. The offering was made to GHS Investments under an effective Form S-3 registration statement. Counterparty: GHS Investments. Proceeds designated for general working capital.
Why this rating
~$493K raise is ~3.4% of $14.7M market cap—material but not transformational. Warrant dilution (788.4K additional shares at $1.00 strike) is substantial relative to company size; however, offering price premium and timing suggest modest investor confidence. Routine growth-stage financing, not a going-concern or strategic pivot.
See more from October 9, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.